SANSURE BIOTECH INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.13 CNY | -2.16% |
|
-2.63% | -7.26% |
| Jun. 12 | Sansure Biotech's Tuberculosis Diagnostic Kit Gets EU Certification | MT |
| Apr. 26 | Sansure Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on Sansure Biotech Inc.
Price target over the last 5 years
History of analyst recommendation changes
bd1a93f7bed5.Sxutbvu_EXCxk_2tcrz6dgcG1mjGHO9ZQMziqyDS1P4.EVTdWJGLYQiHvpXkKvWSBzNxoBuJVdxreb6w707hop1mbZ8sw95jGt7rtA~58ae4db5dd6eb042f7ed140a54544c54
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
18.13
CNY
Average target price
25
CNY
Spread / Average Target
+37.89%
High Price Target
25
CNY
Spread / Highest target
+37.89%
Low Price Target
25
CNY
Spread / Lowest Target
+37.89%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- 688289 Stock
- Consensus Sansure Biotech Inc.
